This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cazzaniga, M. Articles by Decensi, A. Search for Related Content PubMed PubMed Citation Articles by Cazzaniga, M. Articles by Decensi, A. Related Collections Risk Assessment Risk Assessment: Biomarkers

Atypia and Ki-67 Expression from Ductal Lavage in Women at Different Risk for Breast Cancer

Divisions of ¹ Chemoprevention, ² Pathology and Laboratory Medicine, and ³ Breast Surgery, European Institute of Oncology, Milan, Italy; ⁴ Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; and ⁵ Division of Medical and Preventive Oncology, E.O. Ospedali Galliera, Genoa, Italy

Requests for reprints: Andrea Decensi, Division of Chemoprevention, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy. Phone: 39-02-57489861; Fax: 39-02-57489809. E-mail: andrea.decensi{at}ieo.it.

Purpose: Ductal lavage provides adequate material and detects atypical cells from ducts in women at increased risk of breast cancer, but the clinical significance of this finding is unclear. We studied the prevalence and predictors of atypia in addition to the proliferation-associated antigen Ki-67 expression in ductal lavage done in women at different risk of breast cancer.

Results: Ductal lavage was attempted in 202 women at increased risk and in 16 at average risk. Lavage could not be done in 20 women at increased risk because of anatomic impediments. Seven average-risk women (44%) had samples with inadequate cytology versus 30 women at higher risk (16%; P = 0.014). Atypia was observed in two average-risk women [22%; 95% confidence interval (95% CI), 3-60%]. The prevalence of atypia was 33% in women with a 5-year risk of 1.3% according to the Gail model (25 of 75; 95% CI, 23-45%), 36% in women with an increased probability of or ascertained BRCA mutation (9 of 25; 95% CI, 18-57%), and 52% in women with contralateral breast cancer (27 of 52; 95% CI, 38-66%). Ki-67 expression measured in a consecutive series of 80 women at increased risk was higher in atypical samples (P = 0.0001) and was positively associated with total cell count per slide (P = 0.002).

Conclusions: Atypia is frequent in women at increased risk of breast cancer but it can also be found in average-risk women. Ki-67 expression is associated with atypia and cell yield and it might be assessed as a surrogate biomarker in early-phase chemoprevention trials. (Cancer Epidemiol Biomarkers Prev 2006;15(7):1311–5)

This article has been cited by other articles:

				C. J. Fabian Is There a Future for Ductal Lavage? Clin. Cancer Res., August 15, 2007; 13(16): 4655 - 4656. [Full Text] [PDF]

				B. Arun, V. Valero, C. Logan, K. Broglio, E. Rivera, A. Brewster, G. Yin, M. Green, H. Kuerer, Y. Gong, et al. Comparison of Ductal Lavage and Random Periareolar Fine Needle Aspiration as Tissue Acquisition Methods in Early Breast Cancer Prevention Trials Clin. Cancer Res., August 15, 2007; 13(16): 4943 - 4948. [Abstract] [Full Text] [PDF]